Bicocca Open Archive

Logo unimib boa
FAGIUOLI, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.604
AS - Asia 20.008
EU - Europa 12.049
SA - Sud America 2.897
AF - Africa 468
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 21
Totale 56.079
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.925
SG - Singapore 6.945
HK - Hong Kong 3.886
VN - Vietnam 3.822
RU - Federazione Russa 3.017
CN - Cina 2.549
IT - Italia 2.209
BR - Brasile 2.151
IE - Irlanda 1.773
CA - Canada 1.488
DE - Germania 1.462
SE - Svezia 1.246
IN - India 672
FR - Francia 595
GB - Regno Unito 447
BD - Bangladesh 325
AR - Argentina 273
KR - Corea 256
UA - Ucraina 254
IQ - Iraq 235
FI - Finlandia 225
ID - Indonesia 205
TR - Turchia 180
NL - Olanda 169
ZA - Sudafrica 148
PK - Pakistan 146
AT - Austria 128
MX - Messico 118
ES - Italia 114
JP - Giappone 114
PH - Filippine 107
SA - Arabia Saudita 107
EC - Ecuador 104
CO - Colombia 98
PL - Polonia 92
VE - Venezuela 89
MY - Malesia 65
UZ - Uzbekistan 58
DK - Danimarca 55
EG - Egitto 53
CL - Cile 49
PY - Paraguay 49
BE - Belgio 45
KE - Kenya 45
MA - Marocco 43
JO - Giordania 38
TN - Tunisia 37
PE - Perù 36
DZ - Algeria 33
AE - Emirati Arabi Uniti 30
CZ - Repubblica Ceca 30
ET - Etiopia 30
NP - Nepal 30
AZ - Azerbaigian 26
AU - Australia 24
RO - Romania 23
BO - Bolivia 21
LB - Libano 21
LT - Lituania 21
AL - Albania 20
IL - Israele 20
TH - Thailandia 20
UY - Uruguay 20
CH - Svizzera 19
JM - Giamaica 19
PT - Portogallo 19
TW - Taiwan 19
SN - Senegal 18
OM - Oman 17
PS - Palestinian Territory 17
IR - Iran 14
PA - Panama 13
AO - Angola 12
BG - Bulgaria 12
CR - Costa Rica 12
EU - Europa 12
KG - Kirghizistan 12
LY - Libia 11
DO - Repubblica Dominicana 10
GR - Grecia 10
KZ - Kazakistan 10
RS - Serbia 9
BH - Bahrain 8
NO - Norvegia 8
SK - Slovacchia (Repubblica Slovacca) 8
BY - Bielorussia 7
GA - Gabon 7
HU - Ungheria 7
KW - Kuwait 7
HN - Honduras 6
MD - Moldavia 6
MM - Myanmar 6
MN - Mongolia 6
NG - Nigeria 6
QA - Qatar 6
XK - ???statistics.table.value.countryCode.XK??? 6
CI - Costa d'Avorio 5
EE - Estonia 5
SY - Repubblica araba siriana 5
CY - Cipro 4
Totale 55.994
Salva come PNG Salva come JPEG
Città #
Hong Kong 3.828
Singapore 3.710
Ashburn 1.885
Dublin 1.719
San Jose 1.618
Toronto 1.294
Ann Arbor 1.271
Ho Chi Minh City 1.211
Frankfurt am Main 1.034
Hanoi 993
New York 967
Princeton 886
Fairfield 672
Chicago 670
Chandler 662
Santa Clara 654
The Dalles 653
Dallas 565
Milan 529
Los Angeles 515
Woodbridge 464
Houston 462
Lauterbourg 422
Moscow 363
Beijing 340
Lawrence 327
Altamura 321
Wilmington 317
Hefei 285
Seattle 259
Cambridge 249
Buffalo 241
Seoul 239
São Paulo 199
Shanghai 186
Jacksonville 171
Rome 170
San Diego 163
Pune 162
Dearborn 143
Da Nang 136
Helsinki 133
Jakarta 133
Haiphong 124
Council Bluffs 118
London 109
Baghdad 100
Orem 97
Tokyo 92
Andover 89
Salt Lake City 87
Rio de Janeiro 85
Nuremberg 84
Hải Dương 74
Guangzhou 70
Johannesburg 70
Quận Bình Thạnh 69
Chennai 67
Warsaw 67
Vienna 66
Munich 65
Washington 65
Nanjing 62
Brooklyn 59
Thái Nguyên 57
Biên Hòa 54
Atlanta 53
Dhaka 53
Montreal 53
Boston 50
Ha Long 50
Phoenix 50
Hangzhou 49
Tashkent 47
Denver 46
Vũng Tàu 46
Ninh Bình 44
Stockholm 44
Mumbai 43
Lahore 42
Amsterdam 41
Boardman 41
Brasília 40
Can Tho 39
Fremont 39
San Francisco 38
Belo Horizonte 37
Columbus 37
Istanbul 37
Lappeenranta 37
Quito 37
Riyadh 37
Tampa 37
Bắc Ninh 36
Kuala Lumpur 36
Nairobi 35
New Delhi 35
Guayaquil 34
Jeddah 34
Elk Grove Village 33
Totale 34.461
Salva come PNG Salva come JPEG
Nome #
Long-term outcomes of Yttrium-90 transarterial radioembolization for patients with hepatocellular carcinoma 1.309
Immunosuppression in adult liver transplant recipients: a 2024 update from the Italian Liver Transplant Working Group 487
Estimation of lifetime costs for patients receiving a transplant: the case of liver transplantation related to hepatitis B in Italy 467
Vaccinations in Paediatric Solid Organ Transplant Candidates and Recipients 460
Clinical outcome indicators in chronic hepatitis B and C: A primer for value-based medicine in hepatology 445
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine 380
Value-based outcome indicators in the management of hepatocellular carcinoma: Clinical test in a large multicenter study (VBMH study) 346
Waiting list mortality and 5-year transplant survival benefit of patients with MASLD: An Italian liver transplant registry study 343
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 332
A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis 329
Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohort 319
Health related quality of life in chronic liver diseases 316
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 309
Generation and performance of value-based outcome indicators in liver disease: The multicenter V.B.M.H. study 303
Outcome indicators in liver cirrhosis: Application of value-based medicine in a large multicenter study (VBMH study) 300
HCC persistence or recurrence after bridging therapy helps predict transplant list dropout and generate a more equitable exception policy 299
High rates of 30-day mortality in patients with cirrhosis and COVID-19 293
Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 292
P1169 : Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 292
Outcome Indicators in Primary Sclerosing Cholangitis: Interim Analysis Of The Value-Based Medicine In Hepatology (VBMH) Study 292
The impact of liver disease on the health-related quality of life 288
Frequency, characteristics, and outcome of patients with COVID-19 pneumonia and "silent hypoxemia" at admission: a severity-matched analysis 286
Value-based outcome indicators in liver cirrhosis: validation in a large multicenter study (VBMH study) 279
A Comparison Between The Health-Related Quality Of Life Reported By The General Population And By Patients With Major Liver Diseases 278
Measurement of clinical outcomes and quality of life indicators as a new value-based approach to liver cirrhosis management 277
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis 274
Fibrinolytic Proteins and Factor XIII as Predictors of Thrombotic and Hemorrhagic Complications in Hospitalized COVID-19 Patients 272
Generation and Performance of Outcome Indicators in Liver Cirrhosis: The Value Based Medicine in Hepatology Study (V.B.M.H.) 272
Impatto dei farmaci anti virali ad azione diretta sulla cura dei pazienti con epatite C: un approccio di value-based medicine 267
Health Related Quality of Life in the Major Liver Conditions 265
A value-based approach to the management of patients with liver cirrhosis through the systematic measurement of clinical outcome and quality of life indicators 265
The Impact of Type of Liver Conditions on the Patients’ Health Related Quality of Life 262
COVID-19: role of resilience on the psychological impact of lockdown in liver transplant transitional candidates and recipients COVID-19: ruolo della resilienza sull’impatto psicologico del lockdown nei candidati e nei riceventi del trapianto di fegato (adolescenti-giovani adulti) 260
Value-based approach to hepatocellular carcinoma: outcome indicators tested in a large multicenter study (VBMH study) 252
Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching 250
Antecedent use of renin-angiotensin system inhibitors is associated with reduced mortality in elderly hypertensive Covid-19 patients 248
Comparing the performance of the standard EQ-5D 3L with the new version EQ-5D 5L in patients with chronic hepatic diseases 246
Liver transplantation for patients with acute-on-chronic liver failure (ACLF) in Europe: results of the ELITA/EF-CLIF collaborative study (ECLIS) 246
Vaccination Recommendations in Solid Organ Transplant Adult Candidates and Recipients 245
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid 239
Treatment of hepatocellular carcinoma: A cost analysis of yttrium-90 transarterial radioembolization versus sorafenib 238
Balancing donor and recipient risk factors in liver transplantation: The value of D-MELD with particular reference to HCV recipients 236
A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list 236
Applicazione della value-based medicine nella valutazione della cura dei pazienti affetti da epatite. 234
Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous DAA failure 233
Correction: Immunosuppression in adult liver transplant recipients: a 2024 update from the Italian Liver Transplant Working Group (Hepatology International, (2024), 18, 5, (1416-1430), 10.1007/s12072-024-10703-4) 230
Association between inhibitors of the renin-angiotensin system and lung function in elderly patients recovered from severe COVID-19 229
The Italian data on SARS-CoV-2 infection in transplanted patients support an organ specific immune response in liver recipients 226
Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis: a lesson from immunosuppressed patients 226
Renal safety in 3264 HCV patients treated with DAA-based regimens: Results from a large Italian real-life study 224
Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055)) 224
Covid-19 and gender: lower rate but same mortality of severe disease in women-an observational study 222
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 222
Percutaneous management of chronic total occlusion of the portal vein: a retrospective analysis of technical aspects and outcomes 221
Combined double lung-liver transplantation for cystic fibrosis without cardio-pulmonary by-pass. 219
Prediction of progression-free survival in patients presenting with hepatocellular carcinoma within the Milan criteria 216
MicroRNA-425-3p predicts response to sorafenib therapy in patients with hepatocellular carcinoma 216
Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: A European study 215
Delisting HCV-infected liver transplant candidates who improved after viral eradication: Outcome 2 years after delisting 214
Selective use of ex-situ machine perfusion after normothermic regional perfusion in liver transplantation from donation after circulatory death 214
Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination 210
The Role of Imaging in Portal Vein Thrombosis: From the Diagnosis to the Interventional Radiological Management 208
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting 208
Current Endovascular Management of Arterial Complications After Pediatric Liver Transplantation in a Tertiary Center 205
Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C 201
One-year mortality in COVID-19 is associated with patients’ comorbidities rather than pneumonia severity 199
ELITA consensus statements on the use of DAAs in liver transplant candidates and recipients 199
COVID-19 in liver transplant candidates: Pretransplant and post-transplant outcomes - An ELITA/ELTR multicentre cohort study 198
A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis 197
Antibiotic Stewardship Based on Colonization with Multi-Drug-Resistant Bacteria in Liver Transplantation: A Narrative Review 196
Successful pre- and posttransplant sofosbuvir-based anti-hepatitis C virus treatment in persons living with human immunodeficiency virus infection 196
Characterization of compliance phenotypes in COVID-19 acute respiratory distress syndrome 194
Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: Evidence from the Liver Match cohort study 194
Bergamo and Covid-19: How the Dark Can Turn to Light 193
Under-dilated TIPS Associate With Efficacy and Reduced Encephalopathy in a Prospective, Non-randomized Study of Patients With Cirrhosis 193
Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD) after Liver Transplantation: A Narrative Review of an Emerging Issue 191
Non-anatomical revascularization of the portal vein in children with non-cirrhotic extrahepatic portal vein obstruction 189
A Bayesian methodology to improve prediction of early graft loss after liver transplantation derived from the Liver Match study 186
Liver transplantation for HBV-related liver disease: Impact of prophylaxis for HBV on HCC recurrence 184
AFP score and metroticket 2.0 perform similarly and could be used in a “within-ALL” clinical decision tool 183
Antiviral therapy and fibrosis progression in patients with mild-moderate hepatitis C recurrence after liver transplantation. A randomized controlled study 180
Correction: Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19 (Leukemia, (2021), 35, 9, (2710-2714), 10.1038/s41375-021-01299-x) 179
Extended criteria liver donation after circulatory death with prolonged warm ischemia: a pilot experience of normothermic regional perfusion and no subsequent ex-situ machine perfusion 179
The SURF (Italian observational study for renal insufficiency evaluation in liver transplant recipients): A post-hoc between-sex analysis 178
Preparing for future waves and pandemics: a global hospital survey on infection control measures and infection rates in COVID-19 174
Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis 174
Final Results from the First European Real-World Experience on Lusutrombopag Treatment in Cirrhotic Patients with Severe Thrombocytopenia: Insights from the REAl-World Lusutrombopag Treatment in ITalY Study 172
Physiological reno-portal bypass in liver transplantation with non-tumorous portal vein thrombosis 172
HLA-DRB1 donor-recipient mismatch affects the outcome of hepatitis C disease recurrence after liver transplantation 171
R3-AFP score is a new composite tool to refine prediction of hepatocellular carcinoma recurrence after liver transplantation 171
A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort 170
Liver transplantation for HCV cirrhosis: Improved survival in recent years and increased severity of recurrent disease in female recipients: Results of a long term retrospective study 167
Management of infections pre- and post-liver transplantation: report of an AISF consensus conference 167
Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trial 161
Impact of immunosuppressive therapy on the severity of COVID-19 in solid organ transplant recipients 161
Reply to: Correspondence on “High rates of 30-day mortality in patients with cirrhosis and COVID-19” 160
Consensus conference on TIPS management: Techniques, indications, contraindications 160
Citolisi e colestasi post-oltx per cirrosi HCV: l’enigma della diagnosi differenziale 160
Prognostic scores for ursodeoxycholic acid-treated patients predict graft loss and mortality in recurrent primary biliary cholangitis after liver transplantation 159
Open versus laparoscopic cholecystectomy in acute cholecystitis. Systematic review and meta-analysis 159
Totale 24.977
Salva come PNG Salva come JPEG
Categoria #
all - tutte 239.460
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 239.460
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021224 0 0 0 0 0 0 0 0 0 0 79 145
2021/20223.656 81 115 168 213 68 155 43 1.395 86 314 245 773
2022/20235.072 798 1.485 460 295 306 871 64 292 218 61 150 72
2023/20245.053 74 128 152 226 754 1.452 973 162 461 73 64 534
2024/202514.328 822 1.742 601 606 1.226 389 614 462 2.010 1.826 966 3.064
2025/202625.127 2.866 1.925 1.987 2.256 2.707 1.476 3.916 1.460 2.382 2.405 1.747 0
Totale 57.730